De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms
Dr. Rico Buchli and the HLA Protein Technologies team provide answers to questions from their webinar on next-generation soluble HLA peptide discovery platforms to strengthen early immunotherapy R&D.
De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms
In this webinar, Rico Buchli, PhD, shares how next-generation soluble HLA peptide discovery platforms can strengthen early immunotherapy R&D - from target identification and confirmation to receptor/drug validation and translational decision-making.
Vevo Ask The Experts: Oncology Imaging
Experts at FUJIFILM VisualSonics explore how the Vevo F2 can advance oncology research through high-resolution ultrasound and photoacoustic imaging.
Integrating Functionalized Multi-omics in Oncology Drug Discovery
Discover how cutting-edge multi-omics approaches and Generative AI are reshaping oncology drug discovery.
Deconstructing the Effects of Dietary Fat on Intestinal Cellular Networks
Join Semir Beyaz, PhD as he discusses the effects of dietary fat on the intestinal epithelium, immune cells, and the gut microbiome.
The Translational Utility of Ultrasound and Photoacoustics in Head and Neck Oncology
Dr. Mukund Seshadri presents his interdisciplinary research on developing and evaluating ultrasound and photoacoustic imaging for oral oncology applications, with a focus on the prognostic utility of these methods in assessing treatment responses in head and neck cancer patients.
Video Interview – ALZET Osmotic Pumps
Clarisa Peer discusses ALZET Osmotic Pumps, the gold standard for controlled, automatic dosing of compounds in various research areas, including neuroscience, cancer research, cardiovascular, endocrinology, pharmacology research, and more.
Discussing Industry Trends in Home Cage Monitoring with UiD
InsideScientific recently interviewed Jose Gadea, VP of Sales and Marketing from Unified Information Devices, where he explained the company's approach to innovation and highlighted their RFID-enabled, Mouse Matrix system.
Cancer Immunotherapy: Viruses, Vaccines, and other Immuno-Oncology Treatments
In this blog post, current cancer immunotherapy treatments are discussed, as well as some future directions for this rapidly developing field.
#ExpertAnswers: Danielle Senador and Cole McLarty on Biotelemetry
Danielle Senador and Cole McLarty introduce EndoGear, the newest biotelemetry system in the life science field.
#ExpertAnswers: Fiona McBryde on Blood Pressure and Flow
Fiona McBryde discusses the relationship between blood pressure and blood flow to understand organ perfusion in health and disease states.
An Integrated Understanding of Pressure and Flow – An Essential Partnership
Fiona McBryde, PhD shares her research that focuses on the relationship between blood pressure and blood flow to understand organ perfusion in health and disease states.
Cutting Edge Conversations 2022
The Cutting Edge Conversations series offers a deep dive into specific research areas and focused insights regarding market-relevant processes from respected firms in the industry.
Cutting Edge Conversations: Discovering New Innovations in Oncology
Experts discuss progress in cancer research, including novel treatments, experimental therapies, and drug development.
Cutting Edge Conversations: Biomarkers – Challenges and Opportunities
The 5th and final episode in the Cutting Edge Conversation series for 2021 features Dr. Morad Nakhleh, Natalie Smith, and Dr. Bhavika Patel as they discuss industry challenges and innovations surrounding biomarkers in life science research and precision medicine
Cutting Edge Conversations: Challenges in Sourcing Human Biosamples
Richard Kondo, McLean Collins, and Cathie G. Miller highlighted Episode 3 of the Cutting Edge Conversations series focused on innovations in the area of sourcing human biosamples for research. The event focused on sourcing human samples for research, including the value and necessity of working with human tissue during drug discovery, as well as some of the distinct challenges researchers face.
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Join Dr. Danyi Wen as she describes a novel drug efficacy test using Patient Derived Xenograft (PDX) samples to measure drug efficacy and identify therapeutic candidates in personalized oncology treatments.
Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision Medicine Era
Plasma proteomics is increasingly recognized as a fundamental approach to accelerate biomarker discovery and drug development, taking precision medicine to the next level.
Cutting Edge Conversations: The Role of In Vivo Studies in Personalized Medicine
Grace Walton, Jonathan Nakashima, and Meghan Loy kick off Episode 1 of Scientist.com's Cutting Edge Conversations series with a presentation on fundamentals and future trends around the role of in vivo studies in personalized medicine
Bruker Micro-CT/XRM User Meeting
A two-day virtual user meeting showcasing state-of-the-art applications in both life and material sciences, and provides the latest Bruker news about hardware and software.
Academy of Surgical Research Virtual Annual Meeting 2021
Register to watch the on-demand 37th Academy of Surgical Research Virtual Meeting, a three-day exploration of surgical techniques, innovative research, and technology advancements.
#ExpertAnswers: Marcela Maus on Inflammation and Immunophysiology
Dr. Marcela Maus discusses the components and technologies used in making a T cell product, important considerations for efficacy, and underlying mechanisms of toxicity and resistance.
#ExpertAnswers: Christian Schnell on Pharmacology Studies in Oncology Research
Christian Schnell, Associate Director of Oncology at Novartis in Basel, answers questions on PK-PD assessment and corresponding antitumor activity in pharmacology studies for oncology research.
PMOD Virtual User Meeting – SNMMI ’21
The theme for 2021's PMOD User Meeting is all about "Tips & tricks for tracer evaluation and longitudinal studies." And our expert speakers will use their experience in development of novel radionuclides for theranostics and fully quantitative PET in tracer evaluation to demonstrate these important topics.
International COVID-19 Network at Work Virtual Panel – Part 2
Join prominent members of the International COVID-19 Network for a 2-part virtual panel where they will present the advantage of exchanging data and their results along detection, outcome prediction and Long-COVID risks and monitoring.
